Investigators concluded that the encouraging oncologic outcomes coupled with a favorable safety profile warrant further ...

MIAMI - Not long ago, a Stage 4 pancreatic cancer diagnosis was considered a death sentence. But survival rates are improving and one Miami man is living proof! Manny Garcia has a second chance at ...

FDA approves zenocutuzumab for advanced non-small-cell lung cancer and pancreatic cancer with NRG1 fusion, offering new hope ...

An FDA-approved drug used to treat multiple myeloma and lymphoma also shrank tumors in non-small cell lung cancer (NSCLC) ...

Merck (NYSE:MRK) said a Phase 3 study of its drug Keytruda in the treatment of a certain type of ovarian cancer met its ...

Donald Trump has a new crush, and his name is Prince William! The president-elect of the United States gushed over the future ...

The selection of this first target is a key step for the partnership between Medigene and WuXi Biologics, which aims to advance multiple TCR-TCEs over the next three years. The collaboration seeks to ...

Intech Investment Management LLC purchased a new stake in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) in the third quarter, HoldingsChannel.com reports. The institutional ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Rare NRG1 Fusion Therapeutics ...

For the second time this year, University of Pennsylvania spinout Carisma Therapeutics is cutting jobs and narrowing its ...

The maximum tolerated dose (MTD) of SON-1010 was set at 1200 ng/kg, without dose-limiting toxicity or evidence of cytokine release syndrome at ...